Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial.
By J. Bissler, J. C. Kingswood, E. Radzikowska, B. Zonnenberg, M. Frost, E. Belousova, M. Sauter, N. Nonomura, S. Brakemeier, P. D. de Vries and 7 more. The Lancet, 2013
811 citations recorded by the source corpus.
Subfields: Molecular Biology, Oncology, Physiology
View Paper: https://www.semanticscholar.org/paper/e5499c9aec3b95a77e24f7890cc6d35d9ae28f25
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
Citations in the corpus
- Predicting Clinical Events by Combining Static and Dynamic Information Using Recurrent Neural Networks (2016, methodology): “The database has been the basis for many studies in the past [2], [3], [4], [5].”
- The PI3K pathway in human disease (2017, neutral): “Commonly observed brain lesions are cerebral hamartomas and subepen-dymal giant cell tumors (SEGAs) (Franz et al., 2014; Jo´ (cid:1) zwiak et al., 2016).”